Appointment of Whole Time Company Secretary
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd has informed BSE about the proposed appointment of Mr. Dikshant Singh Panwar (Membership No. ACS 42741) as the new Company Secretary of the company. The appointment is being made to fill the vacancy left by the resignation of the previous Company Secretary. The appointment will be formally confirmed in the next board meeting. Mr. Panwar has extensive experience in compliance services and meets all eligibility criteria under the Companies Act, 2013, and SEBI regulations. The intimation was signed by Ms. Chaitali Kalpataru Shah, Director & CFO of the company.
This is a routine compliance-related update to fill a KMP vacancy, with no expected material impact on the stock price or shareholder value. It indicates the company is maintaining its statutory compliance requirements.